Lexeo Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-54.6M | $-55.2M | $672.0K | $1.8M |
| FY2023 | $-59.5M | $-59.6M | $115.0K | $3.0M |
| FY2024 | $-81.2M | $-81.6M | $481.0K | $12.5M |
| FY2025 | $-98.6M | $-99.0M | $397.0K | $12.1M |